joint
fluid
mostli
involv
technic
factor
select
collect
materi
evid
blood
contamin
specimen
handl
consider
includ
sampl
submiss
includ
locat
aspir
signal
present
sign
anim
current
medic
administ
consist
preanalyt
qualiti
control
report
specimen
downstream
clinic
decis
make
manag
patient
acceler
improv
gener
practition
alway
feel
comfort
contact
diagnost
laboratori
specif
inform
regard
sampl
acquisit
process
submiss
joint
point
interact
movement
adjac
bone
hyalin
cartilag
overlay
subchondr
bone
contact
surfac
chondrocyt
within
articular
cartilag
produc
proteoglycan
present
cartilag
articular
space
enclos
joint
capsul
joint
capsul
compos
tough
fibrou
extern
surfac
vascular
subsynovi
layer
line
synovi
surfac
synovium
thin
contain
type
cell
synoviocyt
cell
either
phagocyt
thu
similar
macrophag
type
synoviocyt
produc
hyaluron
acid
glycosaminoglycan
type
b
synoviocyt
type
synoviocyt
visual
cytolog
prepar
synovi
fluid
typic
difficult
differenti
normal
joint
classifi
togeth
larg
mononuclear
cell
synovi
fluid
nondiseas
joint
ultrafiltr
plasma
modifi
secret
hyaluron
acid
glyocoprotein
macromolecul
smaller
molecul
glucos
electrolyt
occur
synovi
fluid
concentr
equival
plasma
protein
plasma
howev
includ
synovi
dialys
limit
extent
synovi
fluid
serv
major
purpos
first
provid
sourc
nutrit
wast
remov
articular
chondrocyt
second
joint
fluid
lubric
oppos
articular
cartilag
surfac
limit
friction
wear
contact
although
hyaluron
acid
lubric
properti
glycoprotein
primari
sourc
reduc
friction
joint
motion
compon
joint
becom
diseas
injur
andor
inflam
patholog
frequent
reflect
chang
within
synovi
fluid
evid
abnorm
condit
includ
joint
effus
decreas
viscos
increas
protein
content
increas
number
inflammatori
cell
chang
percentag
differ
cell
type
present
intraarticular
hemorrhag
synovi
fluid
analysi
critic
aspect
workup
anim
exhibit
joint
issu
whether
concern
primari
maladi
local
one
limb
reflect
secondari
manifest
system
condit
importantli
data
must
integr
clinic
laboratori
find
includ
cultur
serolog
antinuclear
antibodi
titer
rheumatoid
factor
titer
common
indic
collect
synovi
fluid
includ
orthoped
lame
abnorm
limb
function
gait
articular
pain
andor
distent
fever
unknown
origin
widespread
pain
stiff
difficulti
move
typic
characterist
synovi
fluid
dog
cat
present
tabl
normal
synovi
fluid
light
yellow
clear
observ
particular
materi
volum
aspir
depend
joint
sampl
condit
joint
larg
breed
dog
less
ml
synovi
fluid
expect
joint
ml
fluid
collect
stifl
joint
volum
joint
fluid
obtain
dog
hip
dysplasia
rang
ml
joint
small
dog
cat
typic
yield
ml
synovi
fluid
routin
steril
techniqu
follow
arthrocentesi
procedur
includ
clip
fur
thorough
scrub
area
clinician
judg
amount
restraint
sedat
anesthesia
need
accomplish
joint
fluid
collect
absenc
complic
ultrasonographi
frequent
use
recommend
guid
arthrocentesi
procedur
character
joint
lesion
human
unwant
event
includ
blood
contamin
retriev
insuffici
volum
synovi
fluid
scratch
articular
surfac
damag
local
blood
vessel
nerv
synovi
membran
remov
needl
joint
plunger
syring
releas
elimin
neg
pressur
brief
descript
recommend
approach
synovi
fluid
collect
articular
joint
provid
tabl
noninfecti
polyarthr
differenti
diagnosi
recommend
arthrocentesi
perform
multipl
joint
specif
carpi
tarsi
stifl
joint
clinic
sign
commonli
associ
polyarthr
includ
legshift
lame
fever
unknown
origin
joint
pain
note
howev
one
retrospect
studi
document
polyarthr
also
present
simpli
difficulti
walk
without
signific
find
steril
dispos
hypoderm
needl
connect
syring
recommend
research
prefer
needl
attach
syring
felin
arthrocentesi
increas
blood
contamin
note
largerbor
needl
largerbre
dog
sampl
shoulder
elbow
joint
may
necessit
needl
wherea
hip
may
requir
spinal
needl
inflam
synovi
membran
increas
vascular
permeabl
allow
increas
protein
fibrinogen
joint
fluid
often
result
clot
synovi
fluid
sampl
clot
also
occur
signific
hemorrhag
blood
contamin
given
recommend
aliquot
portion
sampl
ethylenediaminetetraacet
acid
edta
tube
prevent
coagul
allow
addit
analys
smallest
edta
blood
tube
avail
use
avoid
erron
result
due
sampl
dilut
excess
anticoagul
small
tube
avail
excess
edta
decant
vessel
ad
sampl
contrast
edta
caus
disrupt
hyaluron
acid
therefor
recommend
evalu
synovi
fluid
viscos
mucin
clot
format
edta
sampl
desir
sampl
provid
tube
contain
particular
anticoagul
red
top
tube
heparin
tube
sampl
cultur
fluid
left
steril
syring
andor
place
aerob
culturett
blood
cultur
tube
red
top
tube
also
may
use
purpos
steril
maintain
increas
likelihood
posit
cultur
recommend
place
synovi
fluid
sampl
blood
cultur
media
avail
synovi
membran
biopsi
cultur
recommend
shown
less
success
yield
posit
cultur
result
synovi
fluid
cultur
addit
synovi
membran
biopsi
consider
invas
traumat
arthrocentesi
sequenti
arthrocentesi
synovi
fluid
analysi
often
perform
part
therapeut
monitor
immunemedi
polyarthr
recogn
arthrocentesi
traumat
procedur
may
elicit
mild
mononuclear
inflamm
howev
one
studi
perform
healthi
dog
show
synovi
fluid
collect
everi
week
result
differ
cell
count
percentag
thu
repeat
collect
use
length
time
consid
less
like
clinic
signific
obscur
evid
therapeut
respons
gross
characterist
synovi
fluid
yield
import
inform
qualiti
patholog
joint
note
time
sampl
collect
even
limit
sampl
avail
direct
smear
prepar
still
possibl
evalu
approxim
volum
color
viscos
turbid
synovi
fluid
sampl
aspir
expel
onto
slide
smear
homogen
red
redting
fluid
indic
hemorrhag
joint
usual
associ
trauma
inflamm
differenti
blood
contamin
discuss
later
articl
xanthochromia
impart
yelloworang
discolor
joint
fluid
due
hemoglobin
breakdown
may
seen
follow
resolut
hemorrhag
overt
sediment
andor
white
light
yellow
color
indic
either
increas
nucleat
cell
count
usual
due
inflamm
infect
neoplasia
presenc
crystal
increas
turbid
result
suspend
particul
matter
may
relat
red
white
cell
fibrin
bacteriaorgan
less
commonli
crystal
rare
crystal
neoplast
cell
alon
caus
chang
color
turbid
import
recogn
normal
synovi
fluid
clot
tube
syring
instead
form
gel
distinct
state
accomplish
agit
sampl
caus
gel
clot
return
fluid
state
revers
fluidgel
phenomenon
call
thixotrop
small
anim
arthrocentesi
often
yield
limit
sampl
volum
scenario
commonli
advis
cytolog
evalu
direct
smear
offer
clinic
relev
inform
avail
synovi
fluid
given
viscos
joint
fluid
squash
compress
prepar
typic
use
gener
direct
smear
recommend
direct
smear
made
immedi
follow
sampl
collect
addit
process
prevent
artifact
misinterpret
due
sampl
age
concentr
dilut
contamin
rough
estim
total
nucleat
cell
count
tncc
differenti
count
character
unusu
cell
may
present
well
subject
assess
proteoglycan
background
possibl
evalu
direct
smear
alon
inde
direct
smear
often
prefer
cytocentrifugeprepar
slide
differenti
cell
count
research
feel
latter
may
provid
accur
represent
cell
proport
morpholog
cell
may
alter
centrifug
particular
diagnosi
suppur
inflamm
reliabl
made
use
direct
smear
sampl
quantiti
allow
recommend
addit
test
includ
tncc
obtain
via
autom
hemocytomet
method
total
protein
mucin
clot
test
concern
bacteri
arthriti
drop
synovi
fluid
cultur
sensit
place
culturett
one
issu
direct
smear
highli
viscou
synovi
fluid
often
yield
thick
prepar
cell
clump
sever
round
cell
easili
identifi
count
tend
problem
howev
joint
diseas
synovi
fluid
dilut
address
thick
sampl
hyaluronidas
ad
synovi
fluid
slide
prepar
recommend
iuml
hyaluronidas
mix
equal
volum
joint
fluid
incub
sever
minut
direct
smear
slide
prepar
use
suggest
use
gentl
smear
techniqu
hyaluronidas
treatment
tend
caus
cell
becom
fragil
direct
smear
alway
evalu
submiss
ensur
adequ
cellular
distribut
synovi
fluid
howev
certain
caveat
emphas
even
pathologist
first
shown
estim
total
cell
count
direct
smear
vari
clinician
clinician
often
overestim
true
cell
number
distinguish
normal
synovi
fluid
synovi
fluid
reflect
degen
joint
diseas
osteoarthr
consist
use
direct
smear
final
direct
smear
use
sole
indic
diseas
progress
evid
therapeut
efficaci
speci
age
breed
gender
anim
provid
key
inform
priorit
potenti
diagnos
exampl
synovi
cell
sarcoma
rare
tumor
anim
occur
far
commonli
dog
cat
clinic
sign
polyarthr
syndrom
akita
typic
appear
month
age
bernes
mountain
dog
highest
preval
system
form
histiocyt
sarcoma
howev
skelet
manifest
diseas
occur
far
commonli
rottweil
golden
retriev
patient
histori
help
character
diseas
process
narrow
differenti
list
exampl
bacteri
septic
arthriti
may
develop
follow
articular
surgeri
local
trauma
direct
inocul
extens
region
infect
hematogen
spread
one
case
septic
arthriti
occur
secondari
migrat
porcupin
quill
report
travel
inch
skin
bacteri
septic
arthriti
often
thought
present
acut
sever
lame
may
also
develop
chronic
mild
pain
without
signific
orthoped
impair
immunemedi
polyarthropathi
associ
varieti
process
vaccin
reaction
drug
reaction
exist
neoplasia
gastrointestin
diseas
idiopath
caus
suspicion
foreign
bodi
reaction
without
secondari
infect
also
reli
complet
discuss
pertin
event
even
event
recent
instanc
onset
sever
arthropathi
report
dog
month
shot
elbow
lead
bullet
interestingli
metal
fragment
mechan
interfer
joint
motion
note
joint
affect
joint
aspir
help
delin
full
extent
diseas
place
emphasi
one
diagnosi
anoth
instanc
inflamm
associ
immunemedi
polyarthropathi
thought
elicit
complement
activ
follow
antigenantibodi
complex
deposit
within
synovium
multipl
joint
note
lesion
commonli
observ
smaller
joint
carpi
tarsi
administr
medic
provid
submiss
form
especi
treatment
direct
disord
differenti
list
includ
system
medic
well
local
region
topic
drug
note
welldemonstr
applic
nonsteroid
antiinflammatori
drug
skin
penetr
local
tissu
synovi
fluid
also
may
pertin
disclos
use
nutraceut
supplement
clinic
trial
support
use
glucosamin
chondroitin
sulfat
turmer
extract
fatti
acid
boswellia
serrata
tree
extract
avocadosoybean
unsaponifi
extract
dog
osteoarthr
surgeri
trauma
prophylact
measur
report
howev
studi
limit
number
remain
need
addit
random
control
clinic
trial
despit
percept
joint
health
product
safe
base
high
valu
absenc
persist
advers
effect
veterinarian
awar
contamin
issu
includ
toxin
pesticid
heavi
metal
metabol
concern
particularli
use
glucosamin
individu
type
diabet
address
human
anim
studi
care
observ
arthrocentesi
may
demonstr
flash
blood
sampl
indic
blood
contamin
altern
diffus
bloodi
sampl
may
indic
sampl
associ
true
hemorrhag
separ
scenario
may
appear
similar
follow
shipment
arriv
laboratori
import
differenti
document
sampl
submiss
synovi
fluid
suppli
tube
syring
store
ship
c
hour
without
signific
loss
cytolog
integr
therefor
recommend
sampl
sent
laboratori
packag
cold
pack
ship
overnight
maintain
sampl
valu
provid
direct
smear
ensur
slide
complet
dri
packag
kept
away
exposur
formalin
fume
refriger
slide
subsequ
condens
may
result
cell
lysi
sever
excel
textbook
review
articl
avail
discuss
approach
analyt
phase
synovi
fluid
evalu
stage
includ
cytolog
evalu
sampl
well
descript
appear
protein
content
viscos
mucin
clot
test
nucleat
cell
count
differenti
particular
reader
refer
wonder
thorough
articl
macwilliam
frederick
publish
compendium
briefli
analyt
phase
cytolog
examin
cell
differenti
count
small
mononuclear
larg
mononuclear
neutrophil
cell
character
nuclear
morpholog
degener
neutrophil
degre
vacuol
indic
activ
macrophag
well
signific
featur
cell
may
present
describ
interpret
sampl
care
screen
presenc
infecti
agent
cell
typic
found
eosinophil
fine
granular
background
tabl
three
gener
categori
arthropathi
veterinari
medicin
associ
differenti
diagnos
noninflammatori
arthropathi
red
xanthochrom
appear
increas
protein
decreas
viscos
normal
poor
mucin
clot
tncc
increas
proport
amount
blood
may
see
hemosiderin
hematoidin
erythrophagia
clear
appear
normal
decreas
protein
viscos
normal
poor
mucin
clot
tncc
normal
moder
increas
small
larg
mononuclear
cell
cell
may
increas
vacuol
coagulopathi
degen
joint
diseas
joint
trauma
joint
trauma
ie
cranial
cruciat
ligament
ruptur
neoplasm
neoplasm
cloudi
appear
normal
increas
protein
normal
decreas
viscos
fair
poor
mucin
clot
tncc
mildli
markedli
increas
neutrophil
specif
process
may
predominantli
mononuclear
eosinophil
inflamm
rather
suppur
compos
synovi
fluid
proteoglycan
chang
proteoglycan
milieu
occur
dilut
also
note
describ
import
rememb
synovi
fluid
evalu
perform
isol
diagnost
test
exampl
presumpt
diagnosi
system
lupu
erythematosu
requir
cytolog
observ
lupu
erythematosu
cell
ragocyt
clinic
sign
antinuclear
antibodi
titer
respons
treatment
also
must
taken
account
addit
rickettsi
infect
suspect
recommend
perform
acut
convalesc
serolog
titer
polymeras
chain
reaction
test
test
produc
fals
neg
depend
specif
etiolog
agent
stage
infect
rare
morula
observ
synovi
fluid
sampl
specif
identif
rickettsi
agent
confirm
cytolog
alon
tabl
provid
summari
variou
arthropathi
encount
veterinari
medicin
